IL136101A - Pharmaceutical compositions containing azelaic acid - Google Patents

Pharmaceutical compositions containing azelaic acid

Info

Publication number
IL136101A
IL136101A IL13610198A IL13610198A IL136101A IL 136101 A IL136101 A IL 136101A IL 13610198 A IL13610198 A IL 13610198A IL 13610198 A IL13610198 A IL 13610198A IL 136101 A IL136101 A IL 136101A
Authority
IL
Israel
Prior art keywords
azelaic acid
pharmaceutical compositions
compositions containing
containing azelaic
composition
Prior art date
Application number
IL13610198A
Other languages
English (en)
Other versions
IL136101A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27217979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL136101(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL136101A0 publication Critical patent/IL136101A0/xx
Publication of IL136101A publication Critical patent/IL136101A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL13610198A 1997-11-19 1998-11-18 Pharmaceutical compositions containing azelaic acid IL136101A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19753044 1997-11-19
US7485098P 1998-02-12 1998-02-12
DE19808086 1998-02-20
PCT/EP1998/007370 WO1999025332A1 (fr) 1997-11-19 1998-11-18 Composition comprenant de l'acide azelaique

Publications (2)

Publication Number Publication Date
IL136101A0 IL136101A0 (en) 2001-05-20
IL136101A true IL136101A (en) 2005-08-31

Family

ID=27217979

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13610198A IL136101A (en) 1997-11-19 1998-11-18 Pharmaceutical compositions containing azelaic acid

Country Status (21)

Country Link
US (1) US6534070B1 (fr)
EP (1) EP1032379B1 (fr)
JP (1) JP3867123B2 (fr)
KR (1) KR100534511B1 (fr)
AT (1) ATE210438T1 (fr)
AU (1) AU743437B2 (fr)
BR (1) BR9814214B1 (fr)
CA (1) CA2311128C (fr)
CZ (1) CZ299116B6 (fr)
DE (2) DE59802473D1 (fr)
DK (1) DK1032379T3 (fr)
ES (1) ES2169566T3 (fr)
HU (1) HU226592B1 (fr)
IL (1) IL136101A (fr)
IS (1) IS2257B (fr)
NO (1) NO327712B1 (fr)
PL (1) PL202454B1 (fr)
PT (1) PT1032379E (fr)
SK (1) SK284338B6 (fr)
TR (1) TR200001393T2 (fr)
WO (1) WO1999025332A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1633374T3 (pl) * 2003-06-10 2008-03-31 Intendis Gmbh Kompozycja kwasów alkanodikarboksylowych i farmaceutycznej substancji czynnej
US20050026982A1 (en) * 2003-06-10 2005-02-03 Soenke Johannsen Composition that consists of alkanedicarboxylic acids and a pharmaceutical active ingredient
DE50305909D1 (de) * 2003-10-13 2007-01-18 Salama Zoser B Pharmazeutische Zusammensetzung umfassend Oxoplatin und dessen Salze
DE10356288B4 (de) 2003-11-28 2014-04-03 Siemens Aktiengesellschaft Röntgendetektorlade
US20060204469A1 (en) * 2005-03-09 2006-09-14 Eric Spengler Stable mixed emulsions
WO2007040598A2 (fr) * 2005-09-19 2007-04-12 Combe Incorporated Systemes d'emulsion stable a tolerance au sel elevee
KR100861978B1 (ko) * 2007-03-22 2008-10-07 한국콜마 주식회사 아젤라산을 이용한 여드름 치료용 화장료 조성물 및 그 제조방법
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
EP2201930A1 (fr) 2008-12-23 2010-06-30 Intendis GmbH Composition d'hydrogel pour le traitement des troubles dermatologiques
US20100247693A1 (en) * 2009-03-24 2010-09-30 Marini Jan L Cosmetic formulation to treat rosacea telangiectasia
PL217786B1 (pl) * 2009-05-28 2014-08-29 P P F Hasco Lek Spółka Akcyjna Żel z kwasem azelainowym i sposób wytwarzania żelu z kwasem azelainowym
BR112012003834A2 (pt) 2009-08-21 2017-08-08 Targeted Delivery Tech Limited métodos para tratamento de distúrbios e para tratamentos de deficiências em ácidos graxos, hipertrigliceridemia ou hipercolesterolemia e pacote
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
GB201205642D0 (en) * 2012-03-29 2012-05-16 Sequessome Technology Holdings Ltd Vesicular formulations
GB201208409D0 (en) * 2012-05-14 2012-06-27 Sequessome Technology Holdings Ltd Vesicular formulations, kits and uses
PL3316856T3 (pl) 2015-06-30 2021-10-25 Sequessome Technology Holdings Limited Zmieszane formulacje
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3811081A1 (de) 1988-03-30 1989-10-12 Schering Ag Verwendung von topisch applizierbaren praeparaten zur behandlung der altershaut
ATE117665T1 (de) * 1990-11-14 1995-02-15 Oreal Amphiphile, nichtionische derivate des glycerins sowie die entsprechenden zwischenprodukte, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen.
GB9316323D0 (en) 1993-08-06 1993-09-22 Procter & Gamble Cosmetic compositions
US5744155A (en) * 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
AU5543294A (en) 1993-10-29 1995-05-22 Pharmos Corp. Submicron emulsions as vaccine adjuvants
ES2094688B1 (es) 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5547989A (en) 1994-08-19 1996-08-20 Schering-Plough Healthcare Products, Inc. Compositions for treating corns and calluses
US5618522A (en) * 1995-01-20 1997-04-08 The Procter & Gamble Company Emulsion compositions
UY24246A1 (es) * 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado

Also Published As

Publication number Publication date
ATE210438T1 (de) 2001-12-15
PT1032379E (pt) 2002-06-28
NO20002487D0 (no) 2000-05-12
CZ20001844A3 (cs) 2000-10-11
CZ299116B6 (cs) 2008-04-30
HUP0004375A2 (hu) 2001-08-28
BR9814214A (pt) 2000-10-03
TR200001393T2 (tr) 2000-10-23
BR9814214B1 (pt) 2010-07-13
IS2257B (is) 2007-06-15
NO327712B1 (no) 2009-09-14
DE19881737D2 (de) 2001-03-22
SK7082000A3 (en) 2001-06-11
ES2169566T3 (es) 2002-07-01
EP1032379B1 (fr) 2001-12-12
HU226592B1 (en) 2009-04-28
NO20002487L (no) 2000-07-18
AU1755199A (en) 1999-06-07
DE59802473D1 (de) 2002-01-24
JP2001522879A (ja) 2001-11-20
CA2311128C (fr) 2008-01-29
DK1032379T3 (da) 2002-04-02
JP3867123B2 (ja) 2007-01-10
EP1032379A1 (fr) 2000-09-06
PL202454B1 (pl) 2009-06-30
PL340631A1 (en) 2001-02-12
CA2311128A1 (fr) 1999-05-27
WO1999025332A1 (fr) 1999-05-27
SK284338B6 (sk) 2005-02-04
KR100534511B1 (ko) 2005-12-08
HUP0004375A3 (en) 2006-06-28
US6534070B1 (en) 2003-03-18
KR20010032229A (ko) 2001-04-16
IS5484A (is) 2000-05-09
AU743437B2 (en) 2002-01-24
IL136101A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
IL136101A0 (en) Pharmaceutical compositions containing azelaic acid
IL135951A0 (en) Antimutagenic compositions for the treatment and prevention of photodamage to skin
AU6628496A (en) Polyether block copolymer micellar compositions for targeting biological agents
EP1045636A4 (fr) Compositions pharmaceutiques et procede d'utilisation de ces dernieres pour traiter des tissus myocardiques defaillants
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
WO2002019981A3 (fr) Compositions cosmetiques et pharmaceutiques et leur utilisation
UA37259C2 (uk) Активна речовина для одержання лікарських засобів при лікуванні дисфункціональних маткових кровотеч
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
WO2002026191A3 (fr) Procedes, compositions et dispositifs utilisant des cellules/capsules urticantes pour administrer un agent therapeutique ou cosmetique dans un tissu
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
AU2001274374A1 (en) Matrix protein compositions for dentin regeneration
WO2000001415A3 (fr) Utilisation d'inhibiteurs de la proteine kinase c epsilon dans le traitement de la douleur
CA2279184A1 (fr) Compositions pharmaceutiques contenant de l'ibuprofene et de la domperidone pour le traitement de la migraine
WO2001041747A3 (fr) Preparation pharmaceutique pour traiter des affections tumorales
WO2001022917A3 (fr) Compositions effervescentes comportant du nimesulide
MY129121A (en) Composition with azelaic acid
WO2000010590A3 (fr) Traitement anticancereux
AU6725300A (en) Non-hygroscopic salts of active ingredients having therapeutical and/or nutritional activities and orally administrable compositions containing same
DK0934342T3 (da) Præparat indeholdende chitosan
FR2547730B1 (fr) Medicament hypolipidemiant contenant comme ingredient actif la d-3-acetoxy-cis-2,3-dihydro-5-(2-(dimethylamino)ethyl)-2-(p-methoxyphenyl)-1,5-benzothiazepine-4(5h)-one ou un de ses sels d'addition d'acides acceptables en pharmacie
TNSN03024A1 (fr) Composition sous forme d'emulsion appropriee pour le traitement de l'hyperhidrose et/ou bromhidrose plantaire
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
WO2000076454A3 (fr) Compositions therapeutiques a usage ophtalmique et compositions therapeutiques destinees au traitement des lesions cerebrales centrales
MX9709684A (es) Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired